CLOs on the Move

Presbyterian Homes and Services

www.preshomes.org

 
Presbyterian Homes & Services (PHS), based in St. Paul, Minnesota, is a non-profit, faith-based organization providing a broad array of high quality housing choices, and care and service options for older adults. Over 7,100 employees serve more than 26,000 older adults through 59 PHS-affiliated senior living communities in Minnesota, Iowa and Wisconsin, and through Optage® home and community services. PHS is also co-owner of Genevive, the largest geriatric primary care practice in Minnesota, providing comprehensive care for over 15,000 older adults. Established in 1955, PHS has earned the reputation as an innovative leader dedicated to promoting independence, purposeful living, and ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $100-250 Million
  • www.preshomes.org
  • 2845 Hamline Avenue North Suite 200
    Saint Paul, MN USA 55113
  • Phone: 651.631.6100

Executives

Name Title Contact Details

Similar Companies

Houchin Community Blood Bank

Houchin Community Blood Bank is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeoLife International

NeoLife is a pioneer in whole food nutrition supplementation since 1958, with a commitment to end the trend of poor wellness and poverty.

Reliant Rehabilitation

Reliant Rehabilitation is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alamance Regional Medical Center

Alamance Regional Medical Center, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Alamance Regional Medical Center, Inc. is based in Burlington, NC. You can find more information on Alamance Regional Medical Center, Inc. at www.armc.com

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.